Can Tumor Angiogenesis Be Targeted for Cancer Therapy?
Yes, targeting tumor angiogenesis is a promising strategy for cancer therapy. By inhibiting the angiogenic pathways, it is possible to starve the tumor of its blood supply, thereby slowing its growth and spread. Bevacizumab is one such drug that targets VEGF and is used in combination with other therapies to treat certain cancers. However, resistance to anti-angiogenic therapy can develop, and research is ongoing to understand and overcome these challenges.
